Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine measurements project.

Runesson B, Trevisan M, Iseri K, Qureshi AR, Lindholm B, Barany P, Elinder CG, Carrero JJ.

Nephrol Dial Transplant. 2019 Jul 30. pii: gfz142. doi: 10.1093/ndt/gfz142. [Epub ahead of print]

PMID:
31361316
2.

Estimated Glomerular Filtration Rate and the Risk of Cancer.

Xu H, Matsushita K, Su G, Trevisan M, Ärnlöv J, Barany P, Lindholm B, Elinder CG, Lambe M, Carrero JJ.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):530-539. doi: 10.2215/CJN.10820918. Epub 2019 Mar 14.

PMID:
30872279
3.

Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project.

Runesson B, Qureshi AR, Xu H, Gasparini A, Lindholm B, Barany P, Elinder CG, Carrero JJ.

PLoS One. 2019 Jan 16;14(1):e0209440. doi: 10.1371/journal.pone.0209440. eCollection 2019.

4.

Lower serum calcium is independently associated with CKD progression.

Janmaat CJ, van Diepen M, Gasparini A, Evans M, Qureshi AR, Ärnlöv J, Barany P, Elinder CG, Rotmans JI, Vervloet M, Dekker FW, Carrero JJ.

Sci Rep. 2018 Mar 26;8(1):5148. doi: 10.1038/s41598-018-23500-5.

5.

Morphological and clinical findings in Sri Lankan patients with chronic kidney disease of unknown cause (CKDu): Similarities and differences with Mesoamerican Nephropathy.

Wijkström J, Jayasumana C, Dassanayake R, Priyawardane N, Godakanda N, Siribaddana S, Ring A, Hultenby K, Söderberg M, Elinder CG, Wernerson A.

PLoS One. 2018 Mar 7;13(3):e0193056. doi: 10.1371/journal.pone.0193056. eCollection 2018.

6.

Re: Byber et al. in Critical Reviews in Toxicology 2016;46:191-240.

Elinder CG, Nordberg GF.

Crit Rev Toxicol. 2017 Nov;47(10):900-901. doi: 10.1080/10408444.2017.1377151. Epub 2017 Oct 16. No abstract available. Erratum in: Crit Rev Toxicol. 2017 Nov;47(10):i.

PMID:
29035126
7.

eGFR and the Risk of Community-Acquired Infections.

Xu H, Gasparini A, Ishigami J, Mzayen K, Su G, Barany P, Ärnlöv J, Lindholm B, Elinder CG, Matsushita K, Carrero JJ.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1399-1408. doi: 10.2215/CJN.00250117. Epub 2017 Aug 17.

8.

Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy.

Wijkström J, González-Quiroz M, Hernandez M, Trujillo Z, Hultenby K, Ring A, Söderberg M, Aragón A, Elinder CG, Wernerson A.

Am J Kidney Dis. 2017 May;69(5):626-636. doi: 10.1053/j.ajkd.2016.10.036. Epub 2017 Jan 23.

9.

End-stage renal disease after occupational lead exposure: 20 years of follow-up.

Evans M, Discacciati A, Quershi AR, Åkesson A, Elinder CG.

Occup Environ Med. 2017 Jun;74(6):396-401. doi: 10.1136/oemed-2016-103876. Epub 2016 Dec 14.

PMID:
27974496
10.

Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.

Carrero JJ, Grams ME, Sang Y, Ärnlöv J, Gasparini A, Matsushita K, Qureshi AR, Evans M, Barany P, Lindholm B, Ballew SH, Levey AS, Gansevoort RT, Elinder CG, Coresh J.

Kidney Int. 2017 Jan;91(1):244-251. doi: 10.1016/j.kint.2016.09.037. Epub 2016 Dec 4.

11.

Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.

Eriksson JK, Neovius M, Jacobson SH, Elinder CG, Hylander B.

BMJ Open. 2016 Oct 7;6(10):e012062. doi: 10.1136/bmjopen-2016-012062.

12.

Prevalence and recognition of chronic kidney disease in Stockholm healthcare.

Gasparini A, Evans M, Coresh J, Grams ME, Norin O, Qureshi AR, Runesson B, Barany P, Ärnlöv J, Jernberg T, Wettermark B, Elinder CG, Carrero JJ.

Nephrol Dial Transplant. 2016 Dec;31(12):2086-2094. Epub 2016 Oct 13.

13.

[Lack of evidence for the result of "active health management"].

Elinder CG.

Lakartidningen. 2016 Mar 14;113. pii: DYAZ. Swedish. No abstract available.

14.

[New indicator needed for follow up of osteoporosis patients].

Hermansson J, Blom M, Elinder CG, Ponzer S, Sääf M.

Lakartidningen. 2016 Feb 15;113. pii: DT3X. Swedish. No abstract available.

15.

The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness.

Runesson B, Gasparini A, Qureshi AR, Norin O, Evans M, Barany P, Wettermark B, Elinder CG, Carrero JJ.

Clin Kidney J. 2016 Feb;9(1):119-27. doi: 10.1093/ckj/sfv117. Epub 2015 Nov 14.

16.

A health record integrated clinical decision support system to support prescriptions of pharmaceutical drugs in patients with reduced renal function: design, development and proof of concept.

Shemeikka T, Bastholm-Rahmner P, Elinder CG, Vég A, Törnqvist E, Cornelius B, Korkmaz S.

Int J Med Inform. 2015 Jun;84(6):387-95. doi: 10.1016/j.ijmedinf.2015.02.005. Epub 2015 Feb 21.

PMID:
25765963
17.

[2.0 and health care--partly right, but just as often wrong].

Elinder CG.

Lakartidningen. 2014 Sep 17-23;111(38):1583-4. Swedish. No abstract available.

18.

The use of estimated glomerular filtration rate for dose adjustment of medications in the elderly.

Elinder CG, Bárány P, Heimbürger O.

Drugs Aging. 2014 Jul;31(7):493-9. doi: 10.1007/s40266-014-0187-z. Review.

PMID:
24902935
19.

Measuring GFR: a systematic review.

Soveri I, Berg UB, Björk J, Elinder CG, Grubb A, Mejare I, Sterner G, Bäck SE; SBU GFR Review Group.

Am J Kidney Dis. 2014 Sep;64(3):411-24. doi: 10.1053/j.ajkd.2014.04.010. Epub 2014 May 17. Review.

PMID:
24840668
20.

Update on endemic nephropathies.

Wernerson A, Wijkström J, Elinder CG.

Curr Opin Nephrol Hypertens. 2014 May;23(3):232-8. doi: 10.1097/01.mnh.0000444911.32794.e7. Review.

PMID:
24717833
21.

Dietary cadmium exposure and chronic kidney disease: a population-based prospective cohort study of men and women.

Thomas LD, Elinder CG, Wolk A, Åkesson A.

Int J Hyg Environ Health. 2014 Sep;217(7):720-5. doi: 10.1016/j.ijheh.2014.03.001. Epub 2014 Mar 13.

PMID:
24690412
22.

Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study.

Neovius M, Jacobson SH, Eriksson JK, Elinder CG, Hylander B.

BMJ Open. 2014 Feb 18;4(2):e004251. doi: 10.1136/bmjopen-2013-004251.

23.

[It is better use a modern formula than being formal].

Elinder CG, Bárány P, Heimbürger O.

Lakartidningen. 2013 Nov 20-26;110(47):2122. Swedish. No abstract available.

PMID:
24437105
24.

[Drug dosage should be based on renal function].

Elinder CG, Bárány P, Heimbürger O.

Lakartidningen. 2013 Nov 20-26;110(47):2119-20. Swedish. No abstract available.

PMID:
24437103
25.

[Treatment with cinacalcet in secondary hyperparathyroidism for dialysis patients: The will is good--but what about the evidence?].

Bárány P, Elinder CG, Samuelsson O.

Lakartidningen. 2013 Aug 21-Sep 3;110(34-35):1481-3. Swedish. No abstract available.

PMID:
24044187
26.

Clinical and pathological characterization of Mesoamerican nephropathy: a new kidney disease in Central America.

Wijkström J, Leiva R, Elinder CG, Leiva S, Trujillo Z, Trujillo L, Söderberg M, Hultenby K, Wernerson A.

Am J Kidney Dis. 2013 Nov;62(5):908-18. doi: 10.1053/j.ajkd.2013.05.019. Epub 2013 Jul 10.

PMID:
23850447
27.

Dietary cadmium exposure and kidney stone incidence: a population-based prospective cohort study of men & women.

Thomas LD, Elinder CG, Tiselius HG, Wolk A, Akesson A.

Environ Int. 2013 Sep;59:148-51. doi: 10.1016/j.envint.2013.06.008. Epub 2013 Jul 1.

28.

[Unclear on dose adjustment in renal impairment].

Asker-Hagelberg C, Rydberg D, Hentschke M, Holm L, Rosenborg S, Elinder CG.

Lakartidningen. 2013 May 22-28;110(21):1030-2. Swedish. No abstract available.

PMID:
23805768
29.

The increase in renal replacement therapy (RRT) incidence has come to an end in Sweden-analysis of variations by region over the period 1991-2010.

Qureshi AR, Evans M, Stendahl M, Prütz KG, Elinder CG.

Clin Kidney J. 2013 Jun;6(3):352-7. doi: 10.1093/ckj/sft032.

30.

Ascorbic acid supplements and kidney stone incidence among men: a prospective study.

Thomas LD, Elinder CG, Tiselius HG, Wolk A, Akesson A.

JAMA Intern Med. 2013 Mar 11;173(5):386-8. doi: 10.1001/jamainternmed.2013.2296. No abstract available.

PMID:
23381591
31.

[Creatinine is still the most common kidney function assay: Examination of the practice in Sweden].

Allander SV, Larsson A, Marké LA, Svensson MK, Björn W, Elinder CG.

Lakartidningen. 2012 May 9-15;109(19):960-2. Swedish. No abstract available.

PMID:
22734261
32.

Regional variation in use of exogenous and endogenous glomerular filtration rate (GFR) markers in Sweden.

Vilhelmsdotter Allander S, Marké LÅ, Wihlen B, Svensson M, Elinder CG, Larsson A.

Ups J Med Sci. 2012 Aug;117(3):273-8. doi: 10.3109/03009734.2012.664179. Epub 2012 Mar 8.

33.

Decreased kidney function among agricultural workers in El Salvador.

Peraza S, Wesseling C, Aragon A, Leiva R, García-Trabanino RA, Torres C, Jakobsson K, Elinder CG, Hogstedt C.

Am J Kidney Dis. 2012 Apr;59(4):531-40. doi: 10.1053/j.ajkd.2011.11.039. Epub 2012 Feb 1.

PMID:
22300650
34.

Chronic renal failure induced by lead.

Evans M, Elinder CG.

Kidney Int. 2011 Mar;79(6):688-689. doi: 10.1038/ki.2010.508. No abstract available.

35.

[Assessment of renal function--unclear which method is best. Background to SBU investigation of endogenous markers].

Elinder CG, Allander SV, Farrokhnia N.

Lakartidningen. 2010 Dec 8-14;107(49):3138-40. Swedish. No abstract available.

PMID:
21280345
36.

Chronic renal failure from lead: myth or evidence-based fact?

Evans M, Elinder CG.

Kidney Int. 2011 Feb;79(3):272-9. doi: 10.1038/ki.2010.394. Epub 2010 Oct 13. Review.

37.

No survival benefit from early-start dialysis in a population-based, inception cohort study of Swedish patients with chronic kidney disease.

Evans M, Tettamanti G, Nyrén O, Bellocco R, Fored CM, Elinder CG.

J Intern Med. 2011 Mar;269(3):289-98. doi: 10.1111/j.1365-2796.2010.02280.x. Epub 2010 Sep 10. Erratum in: J Intern Med. 2011 Jul;270(1):85-6.

38.

Occupational lead exposure and severe CKD: a population-based case-control and prospective observational cohort study in Sweden.

Evans M, Fored CM, Nise G, Bellocco R, Nyrén O, Elinder CG.

Am J Kidney Dis. 2010 Mar;55(3):497-506. doi: 10.1053/j.ajkd.2009.11.012. Epub 2010 Feb 8.

PMID:
20116912
39.

Decreased kidney function of unknown cause in Nicaragua: a community-based survey.

Torres C, Aragón A, González M, López I, Jakobsson K, Elinder CG, Lundberg I, Wesseling C.

Am J Kidney Dis. 2010 Mar;55(3):485-96. doi: 10.1053/j.ajkd.2009.12.012. Epub 2010 Feb 8.

PMID:
20116154
40.

Variations in graft and patient survival after kidney transplantation in Sweden: caveats in interpretation of center effects when benchmarking.

Elinder CG, Ekberg H, Bárány P, Fehrman-Ekholm I, Jensen G, Nordén G, Schön S, Wennberg L, Qureshi AR.

Transpl Int. 2009 Nov;22(11):1051-7. doi: 10.1111/j.1432-2277.2009.00894.x. Epub 2009 May 27.

41.

Acetaminophen, aspirin and progression of advanced chronic kidney disease.

Evans M, Fored CM, Bellocco R, Fitzmaurice G, Fryzek JP, McLaughlin JK, Nyrén O, Elinder CG.

Nephrol Dial Transplant. 2009 Jun;24(6):1908-18. doi: 10.1093/ndt/gfn745. Epub 2009 Jan 20.

PMID:
19155536
42.

The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.

Evans M, Fryzek JP, Elinder CG, Cohen SS, McLaughlin JK, Nyrén O, Fored CM.

Am J Kidney Dis. 2005 Nov;46(5):863-70.

PMID:
16253726
43.

Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation.

Bruchfeld A, Wilczek H, Elinder CG.

Transplantation. 2004 Sep 15;78(5):745-50.

PMID:
15371680
44.

Association between smoking and chronic renal failure in a nationwide population-based case-control study.

Ejerblad E, Fored CM, Lindblad P, Fryzek J, Dickman PW, Elinder CG, McLaughlin JK, Nyrén O.

J Am Soc Nephrol. 2004 Aug;15(8):2178-85.

45.

Cadmium exposure and distal forearm fractures.

Alfvén T, Elinder CG, Hellström L, Lagarde F, Järup L.

J Bone Miner Res. 2004 Jun;19(6):900-5. Epub 2004 Feb 2.

46.

[Why do patients with kidney diseases end up with a heart of stone? Disturbances in calcium-phosphate balance and chronic inflammation important causes].

Martola L, Elinder CG, Stenvinkel P.

Lakartidningen. 2003 Dec 11;100(50):4180-3. Review. Swedish.

PMID:
14717005
47.

Absence of association between organic solvent exposure and risk of chronic renal failure: a nationwide population-based case-control study.

Fored CM, Nise G, Ejerblad E, Fryzek JP, Lindblad P, McLaughlin JK, Elinder CG, Nyrén O.

J Am Soc Nephrol. 2004 Jan;15(1):180-6.

48.

[Does lead cause renal damage? Surprising results published in a respected journal].

Elinder CG.

Lakartidningen. 2003 May 8;100(19):1736. Swedish. No abstract available.

PMID:
12800302
49.

Environmental lead exposure and chronic renal disease.

Elinder CG, Alvestrand A.

N Engl J Med. 2003 May 1;348(18):1810-2; author reply 1810-2. No abstract available.

PMID:
12728912
50.

Successful transplantation of two children with antiendothelial cell antibodies.

Tydén G, Sandberg J, Elinder CG, Berg U.

Transplant Proc. 2003 Mar;35(2):792-3. No abstract available.

PMID:
12644140

Supplemental Content

Loading ...
Support Center